UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000000522
Receipt number R000000628
Scientific Title A randomized phase III trial of AP(Doxorubicin+Cisplatin) versus DP(Docetaxel+Cisplatin), TC(Paclitaxel+Carboplatin) as adjuvant chemotherrapy in patients with high risk group of endometrial carcinoma
Date of disclosure of the study information 2006/11/15
Last modified on 2019/03/22 22:46:37

No. Disposal Last modified on Item of update
1 Insert 2006/11/15 00:06:33
2 Update 2006/12/04 15:39:06

3 Update 2006/12/26 15:47:36

4 Update 2007/01/29 15:18:46

5 Update 2007/02/28 14:06:39

6 Update 2007/03/30 11:38:11

7 Update 2007/04/27 11:40:06

8 Update 2007/06/06 14:47:55
9 Update 2007/07/09 10:51:37

10 Update 2007/08/21 10:49:15

11 Update 2007/11/15 11:12:43

12 Update 2008/02/04 14:53:36

13 Update 2008/03/18 11:16:19

14 Update 2008/05/15 10:43:56 Key inclusion criteria
Key inclusion criteria
15 Update 2008/05/15 10:49:00 Division name
Division name
16 Update 2008/12/08 18:56:20
17 Update 2009/05/18 14:44:49

18 Update 2009/05/25 11:37:58 Email1
19 Update 2010/02/08 18:23:46 Target sample size
20 Update 2010/02/08 18:28:45 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
21 Update 2010/05/21 17:26:21 Name of person sending information
Name of person sending information
Division name
Email
22 Update 2010/12/20 10:57:59 Recruitment status
23 Update 2011/05/16 14:23:07 Division name
24 Update 2011/11/15 11:27:28 Last follow-up date
25 Update 2013/05/15 13:26:20 Division name
Division name
Institute
Name of secondary funder(s)
Post marketing survey by drug manufacture etc., specified by Japanese law.
26 Update 2015/05/18 21:55:37 Email
Name of person sending information
Name of person sending information
27 Update 2017/05/24 12:52:03 Date trial data considered complete
Date analysis concluded
28 Update 2018/08/13 12:03:09 Recruitment status
29 Update 2019/02/14 14:37:47 Results
30 Update 2019/02/14 14:48:41 Recruitment status
Publication of results
31 Update 2019/03/22 22:46:38 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures